Circassia Pharmaceuticals (CSSPF) Financial Statements

8 Followers

Circassia Pharmaceuticals Financial Overview

Circassia Pharmaceuticals's market cap is currently $344.67M. The company's EPS TTM is $0.0126; its P/E ratio is 36.99; and it has a dividend yield of 1.89%. Circassia Pharmaceuticals is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	£ 48.70M	£ 41.80M	£ 36.80M	£ 31.30M	£ 27.90M
Gross Profit	£ 29.60M	£ 30.20M	£ 26.50M	£ 22.20M	£ 19.00M
Operating Income	£ 10.70M	£ 7.70M	£ 4.60M	£ 1.80M	£ -4.30M
EBITDA	£ 10.70M	£ 12.20M	£ 8.60M	£ 15.20M	£ 3.10M
Net Income	£ 7.00M	£ 3.70M	£ 10.70M	£ 16.10M	£ 3.60M
Balance Sheet
Cash & Short-Term Investments	£ 19.90M	£ 10.90M	£ 19.90M	£ 19.40M	£ 12.60M
Total Assets	£ 76.20M	£ 68.40M	£ 91.50M	£ 98.50M	£ 86.40M
Total Debt	£ 1.00M	£ 1.50M	£ 1.10M	£ 1.00M	£ 1.30M
Net Debt	£ -18.90M	£ -9.40M	£ -18.80M	£ -18.40M	£ -11.30M
Total Liabilities	£ 8.60M	£ 8.90M	£ 7.70M	£ 16.60M	£ 19.60M
Stockholders' Equity	£ 73.70M	£ 59.50M	£ 83.80M	£ 81.90M	£ 66.80M
Cash Flow
Free Cash Flow	£ 15.60M	£ 16.20M	£ 11.30M	£ 6.60M	£ 1.20M
Operating Cash Flow	£ 15.80M	£ 17.20M	£ 11.60M	£ 6.70M	£ 1.40M
Investing Cash Flow	£ -1.20M	£ -1.00M	£ -300.00K	£ -100.00K	£ -200.00K
Financing Cash Flow	£ -5.50M	£ -25.10M	£ -10.50M	£ -500.00K	£ 4.10M

Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

Income Statement >

Circassia Pharmaceuticals Debt to Assets

Balance Sheet >

Circassia Pharmaceuticals Cash Flow

Cash Flow >

Circassia Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >